Skip to content
AnalystLens

PROCTER & GAMBLE Co 8-K Report (Mar 5, 1998)

Reports
Other Events
Filing Date
Filed March 5, 1998
Period End
March 5, 1998
Security
PG
In the record · 2016–202610-K1210-Q328-K226

PG filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 226 current reports (8-K) between 2016 and 2026.

  1. FY2019 annual report10-K · Aug ’19Aug ’19
  2. Leadership change8-K · Jan ’22Jan ’22
  3. Leadership change8-K · Dec ’25Dec ’25

Summary

Summary of the 8-K filed March 5, 1998. Cited figures are marked; the original filing is the authoritative source.

This Form 8-K from The Procter & Gamble Company (PG), filed March 5, 1998, is a narrow disclosure under Item 9 covering an unregistered equity sale.

On February 25, 1998, P&G sold 5,857 shares of common stock to employees of its subsidiaries for approximately $498,073,a relying on Regulation S, the exemption for offers and sales made outside the United States. No underwriter or placement agent was involved. The implied price is roughly $85.04 per share.

The filing contains no financial results, guidance, strategic announcements, or information about operations. The transaction is very small relative to P&G's size. Its proceeds are a rounding error against the company's annual revenue and market capitalization, and the share count is negligible compared with the outstanding common stock.

Shareholders should not expect any material effect on earnings, capital structure, or per-share value from this event. For investors, the filing is best read as a routine regulatory disclosure of an employee-related share issuance.

It is most relevant to those tracking how P&G compensates or incentivizes overseas subsidiary staff, or to those reviewing the company's compliance with securities disclosure requirements. Investment decisions should rest on the company's periodic reports (10-K and 10-Q) and other material disclosures rather than on this filing.

Key Highlights

  1. P&G sold 5,857 shares of common stock on February 25, 1998, to employees of its subsidiaries.
  2. Aggregate proceeds were approximately $498,073, implying roughly $85.04 per share.
  3. The sale was made in reliance on Regulation S, which covers offers and sales outside the United States.
  4. No underwriter or placement agent was used, so no underwriting fees or discounts applied.
  5. The transaction is immaterial to P&G's financial position, earnings, and share count.
  6. The filing contains no financial results, earnings guidance, or operational or strategic updates.
  7. The 8-K was filed under Item 9 (Regulation S sales), a routine disclosure category for unregistered share issuances.

Frequently Asked Questions

  1. Does this 8-K affect P&G's financial performance or share value?

    No. The proceeds of about $498,000 and the 5,857 shares issued are negligible relative to P&G's revenue, earnings, and total shares outstanding. The filing has no measurable impact on per-share metrics or valuation.

  2. What is Regulation S, and why does it matter here?

    Regulation S is an SEC safe harbor that exempts offers and sales of securities made outside the United States to non-U.S. persons from U.S. registration requirements. Because the employees were at foreign subsidiaries, P&G could rely on it instead of registering the shares, which is why the company had to file this disclosure.

  3. Why did P&G sell shares to employees at subsidiaries rather than on the open market?

    The filing does not state the reason. Such sales are typically tied to employee stock purchase or compensation programs that let staff at overseas affiliates acquire company stock. The 8-K does not describe the specific plan, so that interpretation is an inference.

  4. Were any fees or commissions paid in connection with this sale?

    The filing states that no underwriter or placement agent was used, so no underwriting discount or placement commission was reported. The filing does not discuss any other costs.